ATE496139T1 - Kombinationsoligomere betreffende verfahren, kits und zusammensetzungen - Google Patents

Kombinationsoligomere betreffende verfahren, kits und zusammensetzungen

Info

Publication number
ATE496139T1
ATE496139T1 AT06023675T AT06023675T ATE496139T1 AT E496139 T1 ATE496139 T1 AT E496139T1 AT 06023675 T AT06023675 T AT 06023675T AT 06023675 T AT06023675 T AT 06023675T AT E496139 T1 ATE496139 T1 AT E496139T1
Authority
AT
Austria
Prior art keywords
kits
combination oligomers
methods
compositions relating
pna
Prior art date
Application number
AT06023675T
Other languages
English (en)
Inventor
James M Coull
Mark J Fiandaca
Mark D Kristjanson
Jens J Hyldig-Nielsen
Theresa M Creasey
Original Assignee
Boston Probes Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boston Probes Inc filed Critical Boston Probes Inc
Application granted granted Critical
Publication of ATE496139T1 publication Critical patent/ATE496139T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6816—Hybridisation assays characterised by the detection means
    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B20/00—Methods specially adapted for identifying library members
    • C40B20/04—Identifying library members by means of a tag, label, or other readable or detectable entity associated with the library members, e.g. decoding processes
    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B30/00—Methods of screening libraries
    • C40B30/04—Methods of screening libraries by measuring the ability to specifically bind a target molecule, e.g. antibody-antigen binding, receptor-ligand binding
    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B40/00—Libraries per se, e.g. arrays, mixtures
    • C40B40/04—Libraries containing only organic compounds
    • C40B40/06—Libraries containing nucleotides or polynucleotides, or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/11—Compounds covalently bound to a solid support
    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B40/00—Libraries per se, e.g. arrays, mixtures
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/81—Packaged device or kit

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Macromonomer-Based Addition Polymer (AREA)
  • Sealing Material Composition (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Prostheses (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Electric Connection Of Electric Components To Printed Circuits (AREA)
  • Adhesives Or Adhesive Processes (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT06023675T 2001-03-09 2002-03-09 Kombinationsoligomere betreffende verfahren, kits und zusammensetzungen ATE496139T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US27454701P 2001-03-09 2001-03-09

Publications (1)

Publication Number Publication Date
ATE496139T1 true ATE496139T1 (de) 2011-02-15

Family

ID=23048654

Family Applications (2)

Application Number Title Priority Date Filing Date
AT02719163T ATE346950T1 (de) 2001-03-09 2002-03-09 Kombinationsoligomere betreffende verfahren, kits und zusammensetzungen
AT06023675T ATE496139T1 (de) 2001-03-09 2002-03-09 Kombinationsoligomere betreffende verfahren, kits und zusammensetzungen

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT02719163T ATE346950T1 (de) 2001-03-09 2002-03-09 Kombinationsoligomere betreffende verfahren, kits und zusammensetzungen

Country Status (9)

Country Link
US (9) US7256275B2 (de)
EP (2) EP1748078B1 (de)
JP (2) JP4408628B2 (de)
AT (2) ATE346950T1 (de)
AU (1) AU2002250262B9 (de)
CA (1) CA2439750A1 (de)
DE (2) DE60239020D1 (de)
DK (1) DK1412517T3 (de)
WO (1) WO2002072865A2 (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002250262B9 (en) * 2001-03-09 2006-11-30 Boston Probes, Inc. Methods, kits and compositions of combination oligomers
US20040137469A1 (en) 2002-09-08 2004-07-15 Casale Ralph A Methods, compositions and libraries pertaining PNA dimer and PNA oligomer synthesis
JP4608483B2 (ja) * 2003-02-18 2011-01-12 アプライド バイオシステムズ， エルエルシー ポリヌクレオチドの複合的分析のための組成物および方法
EP1674581A1 (de) * 2004-12-21 2006-06-28 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Doppelsonden und ihre Verwendung zum Nachweis von SNPS
US7892737B2 (en) * 2005-06-30 2011-02-22 Life Technologies Corporation Compositions, kits and methods pertaining to stability modulation of PNA oligomer/nucleic acid complexes
GB2433505A (en) * 2005-12-20 2007-06-27 Sharp Kk Capture agents for binding a ligand
GB2433506A (en) * 2005-12-20 2007-06-27 Sharp Kk A method of producing a multimeric capture agent
GB2433591A (en) * 2005-12-20 2007-06-27 Sharp Kk Method for functionalising a hydrophobic substrate
WO2007106690A2 (en) * 2006-03-15 2007-09-20 Siemens Healthcare Diagnostics Inc. Degenerate nucleobase analogs
EP2031074A4 (de) * 2006-08-08 2010-09-08 Arkray Inc Verfahren für variationsnachweis und kit dafür
US20100120031A1 (en) 2006-09-22 2010-05-13 The United States Of America, As Represented By The Secretary, Dept. Of Synthesis of trans-tert-butyl-2-aminocyclopentylcarbamate
GB0718255D0 (en) * 2007-09-19 2007-10-31 Univ Edinburgh Nucleobase characterisation
JP2012502911A (ja) * 2008-09-14 2012-02-02 インサイター インコーポレイテッド ナノスケール分子合成
AU2011230496B2 (en) * 2010-03-26 2015-09-17 Integrated Dna Technologies, Inc. Methods for enhancing nucleic acid hybridization
US9506057B2 (en) 2010-03-26 2016-11-29 Integrated Dna Technologies, Inc. Modifications for antisense compounds
CA2809457C (en) 2010-09-07 2019-07-30 Integrated Dna Technologies, Inc. Modifications for antisense compounds
JP5852222B2 (ja) * 2011-03-29 2016-02-03 シージーン アイエヌシー Ｐｔｏ切断及び延長−依存的切断によるターゲット核酸配列の検出
KR101674778B1 (ko) * 2012-01-07 2016-11-09 가부시키가이샤 보낙 아미노산 골격을 갖는 단일-가닥 핵산 분자
AU2013228226B2 (en) * 2012-03-05 2016-06-02 Seegene, Inc. Detection of nucleotide variation on target nucleic acid sequence by PTO cleavage and extension assay
JP6126088B2 (ja) 2012-05-26 2017-05-10 株式会社ボナック デリバリー機能を有する遺伝子発現制御用の一本鎖核酸分子
CN104703971B (zh) * 2012-08-02 2018-08-21 株式会社百奥尼 新型偶氮化合物及其利用、以及其制造方法
GB201316644D0 (en) * 2013-09-19 2013-11-06 Kymab Ltd Expression vector production & High-Throughput cell screening
CN105899663B (zh) 2013-12-26 2019-07-26 学校法人东京医科大学 用于基因表达控制的人工模拟miRNA及其用途
JP6425142B2 (ja) 2013-12-27 2018-11-21 株式会社ボナック 遺伝子発現制御のための人工マッチ型ｍｉＲＮＡおよびその用途
CN107109415B (zh) 2014-12-27 2021-07-09 株式会社博纳克 控制基因表达的天然型miRNA及其用途
CN108064289A (zh) 2015-03-27 2018-05-22 株式会社博纳克 具有递送功能和基因表达调控能力的单链核酸分子
US11136597B2 (en) 2016-02-16 2021-10-05 Yale University Compositions for enhancing targeted gene editing and methods of use thereof
KR102403904B1 (ko) * 2019-12-24 2022-06-02 주식회사 시선바이오머티리얼스 용액공정상 pna 올리고머의 제조방법
CN113322523B (zh) * 2021-06-17 2024-03-19 翌圣生物科技(上海)股份有限公司 Rna快速建库方法及其应用

Family Cites Families (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
CA1284931C (en) 1986-03-13 1991-06-18 Henry A. Erlich Process for detecting specific nucleotide variations and genetic polymorphisms present in nucleic acids
US5252293A (en) 1989-01-17 1993-10-12 Vladimir Drbal Analytical slide with porous filter membrane
DE3943522A1 (de) * 1989-07-26 1991-02-07 Boehringer Mannheim Gmbh Heterobifunktionelle verbindungen
US5366860A (en) 1989-09-29 1994-11-22 Applied Biosystems, Inc. Spectrally resolvable rhodamine dyes for nucleic acid sequence determination
US5188934A (en) 1989-11-14 1993-02-23 Applied Biosystems, Inc. 4,7-dichlorofluorescein dyes as molecular probes
US5714331A (en) 1991-05-24 1998-02-03 Buchardt, Deceased; Ole Peptide nucleic acids having enhanced binding affinity, sequence specificity and solubility
US5766855A (en) 1991-05-24 1998-06-16 Buchardt, Deceased; Ole Peptide nucleic acids having enhanced binding affinity and sequence specificity
US6451968B1 (en) 1991-05-24 2002-09-17 Isis Pharmaceuticals, Inc. Peptide nucleic acids
US5539082A (en) 1993-04-26 1996-07-23 Nielsen; Peter E. Peptide nucleic acids
US5719262A (en) 1993-11-22 1998-02-17 Buchardt, Deceased; Ole Peptide nucleic acids having amino acid side chains
US5641625A (en) 1992-05-22 1997-06-24 Isis Pharmaceuticals, Inc. Cleaving double-stranded DNA with peptide nucleic acids
DK51092D0 (da) * 1991-05-24 1992-04-15 Ole Buchardt Oligonucleotid-analoge betegnet pna, monomere synthoner og fremgangsmaade til fremstilling deraf samt anvendelser deraf
US5700922A (en) 1991-12-24 1997-12-23 Isis Pharmaceuticals, Inc. PNA-DNA-PNA chimeric macromolecules
GB9211979D0 (en) 1992-06-05 1992-07-15 Buchard Ole Uses of nucleic acid analogues
US5527675A (en) 1993-08-20 1996-06-18 Millipore Corporation Method for degradation and sequencing of polymers which sequentially eliminate terminal residues
DE4331012A1 (de) 1993-09-13 1995-03-16 Bayer Ag Nukleinsäuren-bindende Oligomere mit N-Verzweigung für Therapie und Diagnostik
GB2284209A (en) 1993-11-25 1995-05-31 Ole Buchardt Nucleic acid analogue-induced transcription of RNA from a double-stranded DNA template
GB2289677A (en) 1993-12-06 1995-11-29 Pna Diagnostics As Labelling of nucleic acid analogue-peptide chimerae
DK145493D0 (da) 1993-12-23 1993-12-23 Dako As Antistof
US5539083A (en) 1994-02-23 1996-07-23 Isis Pharmaceuticals, Inc. Peptide nucleic acid combinatorial libraries and improved methods of synthesis
US5705333A (en) 1994-08-05 1998-01-06 The Regents Of The University Of California Peptide-based nucleic acid mimics(PENAMS)
US6280964B1 (en) 1995-04-14 2001-08-28 The Regents Of The University Of California Binding sites for phosphotyrosine binding domains
JP2001518054A (ja) * 1995-06-07 2001-10-09 パーセプティブ バイオシステムズ，インコーポレーテッド Ｐｎａ−ｄｎａキメラと、このキメラ合成用のｐｎａシントン
DE19532553A1 (de) 1995-09-04 1997-03-06 Hoechst Ag Verfahren zur Herstellung substituierter N-Ethyl-Glycinderivate
US6020481A (en) 1996-04-01 2000-02-01 The Perkin-Elmer Corporation Asymmetric benzoxanthene dyes
US5847162A (en) 1996-06-27 1998-12-08 The Perkin Elmer Corporation 4, 7-Dichlororhodamine dyes
SE506700C2 (sv) 1996-05-31 1998-02-02 Mikael Kubista Sond och förfaranden för analys av nukleinsyra
US6110676A (en) 1996-12-04 2000-08-29 Boston Probes, Inc. Methods for suppressing the binding of detectable probes to non-target sequences in hybridization assays
CA2218440A1 (en) 1996-12-21 1998-06-21 Boehringer Mannheim Gmbh Method of analysis using signal amplification
EP0857791B1 (de) * 1996-12-21 2004-03-31 PNA Diagnostics A/S Analyseverfahren basierend auf Signalverstärkung
US6080418A (en) 1997-04-07 2000-06-27 3M Innovative Properties Company Suspensions of microcapsules containing biologically active ingredients and adhesive microspheres
US6107470A (en) 1997-05-29 2000-08-22 Nielsen; Peter E. Histidine-containing peptide nucleic acids
DE69828287T2 (de) 1997-06-13 2005-12-15 Gryphon Therapeutics, Inc., South San Francisco Festphasige native chemische ligation von ungeschützten oder n-cystein-geschützten peptiden in wässrigen lösungen
DK0897991T3 (da) 1997-08-22 2005-07-25 Pna Diagnostics Aps Små triplexdannende PNA-oligoer
US6008379A (en) 1997-10-01 1999-12-28 The Perkin-Elmer Corporation Aromatic-substituted xanthene dyes
EP1025120B1 (de) 1997-10-27 2010-08-18 Boston Probes, Inc. Sich auf "pna molecular beacons" beziehende verfahren, testsätze und zusammensetzungen
US6485901B1 (en) * 1997-10-27 2002-11-26 Boston Probes, Inc. Methods, kits and compositions pertaining to linear beacons
US5936087A (en) 1997-11-25 1999-08-10 The Perkin-Elmer Corporation Dibenzorhodamine dyes
US6080868A (en) 1998-01-23 2000-06-27 The Perkin-Elmer Corporation Nitro-substituted non-fluorescent asymmetric cyanine dye compounds
US6326479B1 (en) 1998-01-27 2001-12-04 Boston Probes, Inc. Synthetic polymers and methods, kits or compositions for modulating the solubility of same
DK1053355T3 (da) 1998-02-11 2002-02-11 Pe Corp Ny PNA- og DNA-konjugater og metoder til fremstilling heraf
US6361942B1 (en) 1998-03-24 2002-03-26 Boston Probes, Inc. Method, kits and compositions pertaining to detection complexes
US6287772B1 (en) 1998-04-29 2001-09-11 Boston Probes, Inc. Methods, kits and compositions for detecting and quantitating target sequences
ATE449868T1 (de) 1998-04-29 2009-12-15 Boston Probes Inc Methoden, testsätze und kompositionen zur detektion und quantifizierung von zielsequenzen
AU4965499A (en) 1998-07-09 2000-02-01 Biocept, Inc. Method of using an improved peptide nucleic acid universal library to optimize dna sequence hybridation
US6248884B1 (en) 1999-06-03 2001-06-19 The Perkin-Elmer Corporation Extended rhodamine compounds useful as fluorescent labels
US6316230B1 (en) * 1999-08-13 2001-11-13 Applera Corporation Polymerase extension at 3′ terminus of PNA-DNA chimera
US6140500A (en) 1999-09-03 2000-10-31 Pe Corporation Red-emitting [8,9]benzophenoxazine nucleic acid dyes and methods for their use
US6297016B1 (en) 1999-10-08 2001-10-02 Applera Corporation Template-dependent ligation with PNA-DNA chimeric probes
US6472153B1 (en) 1999-10-26 2002-10-29 Epoch Biosciences, Inc. Hybridization-triggered fluorescent detection of nucleic acids
US6191278B1 (en) 1999-11-03 2001-02-20 Pe Corporation Water-soluble rhodamine dyes and conjugates thereof
AU2002250262B9 (en) * 2001-03-09 2006-11-30 Boston Probes, Inc. Methods, kits and compositions of combination oligomers

Also Published As

Publication number Publication date
EP1748078B1 (de) 2011-01-19
EP1412517B1 (de) 2006-11-29
DE60216468D1 (de) 2007-01-11
ATE346950T1 (de) 2006-12-15
US7884053B2 (en) 2011-02-08
JP2007209346A (ja) 2007-08-23
US7674585B2 (en) 2010-03-09
JP4408628B2 (ja) 2010-02-03
US20080269074A1 (en) 2008-10-30
AU2002250262B9 (en) 2006-11-30
US20080125332A1 (en) 2008-05-29
US20080206747A1 (en) 2008-08-28
US20070105145A1 (en) 2007-05-10
US7745126B2 (en) 2010-06-29
EP1412517A2 (de) 2004-04-28
US7566420B1 (en) 2009-07-28
AU2002250262B2 (en) 2006-10-26
JP2004524032A (ja) 2004-08-12
WO2002072865A2 (en) 2002-09-19
US20080220987A1 (en) 2008-09-11
EP1748078A3 (de) 2007-02-28
DE60239020D1 (de) 2011-03-03
DK1412517T3 (da) 2007-03-05
CA2439750A1 (en) 2002-09-19
DE60216468T2 (de) 2007-09-27
US20030077608A1 (en) 2003-04-24
US20090163381A1 (en) 2009-06-25
US7256275B2 (en) 2007-08-14
US7851155B2 (en) 2010-12-14
US7638279B2 (en) 2009-12-29
US20080085837A1 (en) 2008-04-10
WO2002072865A3 (en) 2003-11-27
US7605253B2 (en) 2009-10-20
EP1412517A4 (de) 2004-07-07
EP1748078A2 (de) 2007-01-31

Similar Documents

Publication Publication Date Title
ATE346950T1 (de) Kombinationsoligomere betreffende verfahren, kits und zusammensetzungen
DK1663185T3 (da) Forebyggelse og behandling af inflammationsinduceret og/eller immun-medieret knogletab
CY1106366T1 (el) Ενωση λακταμης για την αναστολη της απελευθερωσης ή της συνθεσης βητα-αμυλοειδους πεπτιδιου
NO20062062L (no) Procsesser for preparering av forskjellige former for (S)-(+)-clopidogrel bisulfat
NO20055130D0 (no) Aminocykloheksyleter-forbindelser og deres anvendelse
PT1689232E (pt) Método para a protecção de materiais
DE602004023140D1 (de) Rhamnose-induzierbares Expressionssystem
DE60236814D1 (de) 3-alkyl-5,5',6,6',7,7',8,8'-octahydro-2,2'-binaphthole und 3,3'-dialkyl-5,5',6,6',7,7',8,8'-octahydro-2,2'-binaphthole, sowie verfahren zur ihrer herstellung
ATE286011T1 (de) Verfahren zur herstellung von 1-octen
DE60116076D1 (de) Scherfluidisierende schreibzusammensetzungen, schreibgeräte und verfahren
ATE477342T1 (de) Verfahren zur herstellung von hartmetallgranulat
ATE306491T1 (de) Verfahren zur herstellung von wasserfreiem azithromycin
DK1383742T3 (da) Syntese og fremgangsmåder til anvendelse af tetrahydroindolonanaloge og derivater
ATE406939T1 (de) Schäumende zusammensetzung enthaltend ton
ES1048253Y (es) Bloque de impacto para colada continua.
DE60221039D1 (de) Kosmetische mischung enthaltend ein block-copolymeres
MXPA05005484A (es) Metodo para mejorar las propiedaes fisico-quimicas de composiciones bituminosas y novedosas composiciones bituminosas con propiedades mejoradas y sus usos.
ATE287403T1 (de) 6-phenylbenzonaphthyidine
TR200002755T2 (tr) Aracı hazırlamak için süreç.
DE50107490D1 (de) Stoffgemisch enthaltend bisphenol a
MXPA03010259A (es) Nuevos derivados de 5-tio-ss-d-xilopiranosida, procedimiento de preparacion, composiciones farmaceuticas que los contienen y el uso terapeutico de los mismos.
DE60234943D1 (de) Verfahren zur herstellung von nitrierstahl
TW200500350A (en) Photochromic oxazine compounds and methods for their manufacture
ATE397079T1 (de) Verfahren zur klonierung mittels doppelter selektion und vektoren dafür
BR0210749A (pt) Composições de fragrância e sabor

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties